Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alpha-1 antitrypsin dysfunction and large artery stroke.

Literature DB >> 28348245

Alpha-1 antitrypsin dysfunction and large artery stroke.

James F Meschia¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：
alpha 1-Antitrypsin

Year: 2017 PMID： 28348245 PMCID： PMC5389318 DOI： 10.1073/pnas.1702751114

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

23 in total

1. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study.

Authors: P L Kolominsky-Rabas; M Weber; O Gefeller; B Neundoerfer; P U Heuschmann
Journal: Stroke Date: 2001-12-01 Impact factor: 7.914

Review 2. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.

Authors: Adriano R Tonelli; Mark L Brantly
Journal: Ther Adv Respir Dis Date: 2010-07-22 Impact factor: 4.031

3. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study.

Authors: Lars Marquardt; Olivia C Geraghty; Ziyah Mehta; Peter M Rothwell
Journal: Stroke Date: 2009-11-19 Impact factor: 7.914

Review 4. Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.

Authors: Joanna Wozniak; Tomasz Wandtke; Piotr Kopinski; Joanna Chorostowska-Wynimko
Journal: Hum Gene Ther Date: 2015-09-29 Impact factor: 5.695

Review 5. Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.

Authors: Daniel E Jonas; Cynthia Feltner; Halle R Amick; Stacey Sheridan; Zhi-Jie Zheng; Daniel J Watford; Jamie L Carter; Cassandra J Rowe; Russell Harris
Journal: Ann Intern Med Date: 2014-09-02 Impact factor: 25.391

6. Stroke subtype predicts outcome in young and middle-aged stroke sufferers.

Authors: P Redfors; K Jood; L Holmegaard; A Rosengren; C Blomstrand; C Jern
Journal: Acta Neurol Scand Date: 2012-02-18 Impact factor: 3.209

7. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.

Authors: H J Barnett; D W Taylor; M Eliasziw; A J Fox; G G Ferguson; R B Haynes; R N Rankin; G P Clagett; V C Hachinski; D L Sackett; K E Thorpe; H E Meldrum; J D Spence
Journal: N Engl J Med Date: 1998-11-12 Impact factor: 91.245

Alpha-1 antitrypsin dysfunction and large artery stroke.

1. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study.

Review 2. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.

3. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study.

Review 4. Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy.

Review 5. Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.

6. Stroke subtype predicts outcome in young and middle-aged stroke sufferers.

7. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.

8. Transethnic meta-analysis of genomewide association studies.

9. Magnetic resonance angiography detection of abnormal carotid artery plaque in patients with cryptogenic stroke.

10. Trans-ethnic study design approaches for fine-mapping.

1. Circulating exosomal lncRNAs as predictors of risk and unfavorable prognosis for large artery atherosclerotic stroke.